Lipid profile after switching from a TDF (tenofovir disoproxil)-containing to TAF (tenofovir alafenamide)-containing regimen in virologically suppressed people living with HIV. Journal of Medical Science, Poznań, Poland, v. 92, n. 4, p. e808, 2023. DOI: 10.20883/medical.e808. Disponível em: https://horkruks.ump.edu.pl/index.php/JMS/article/view/808. Acesso em: 17 aug. 2025.